A Phase 3 Study of NBI-98854 for the Treatment of Tardive Dyskinesia

Clinical trial NCT02274558 · COMPLETED

Trial details

NCT number: NCT02274558
Sponsor: Neurocrine Biosciences
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tardive Dyskinesia

Start date: 2014-10-01
Primary completion: 2015-09-01
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.